132 related articles for article (PubMed ID: 3394585)
1. Inhibition of passive cutaneous anaphylaxis by several histamine (H1) and serotonin antagonists in the rat.
Metys J; Frycová H; Soucek R
Agents Actions; 1988 Apr; 23(3-4):331-3. PubMed ID: 3394585
[TBL] [Abstract][Full Text] [Related]
2. LC-6 inhibition of the rat skin reactions is due to mediator release inhibitor and not to mediator antagonism.
Hurtado I; Urbina C
Acta Cient Venez; 1983; 34(1):44-7. PubMed ID: 6424369
[No Abstract] [Full Text] [Related]
3. [Anti-allergic properties of pipethiaden--a new preventive agent for migraine].
Frycová H; Metys J
Cesk Farm; 1989 Jul; 38(6):264-8. PubMed ID: 2790993
[TBL] [Abstract][Full Text] [Related]
4. Anti-allergic effects of ketanserin on animal models of allergic reactions.
Nagai H; Suda H; Kitagaki K; Goto S; Miura T; Koda A
Arch Int Pharmacodyn Ther; 1990; 307():172-82. PubMed ID: 1710442
[TBL] [Abstract][Full Text] [Related]
5. In vivo anti-allergic and bronchopulmonary pharmacology of REV 3164 in rats and guinea-pigs.
Leibowitz M; Gordon RJ; Wolf PS; Sonnino-Goldman P
Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):135-54. PubMed ID: 6497506
[TBL] [Abstract][Full Text] [Related]
6. Participation of histamine H1 and H2 receptors in passive cutaneous anaphylaxis-induced scratching behavior in ICR mice.
Inagaki N; Nakamura N; Nagao M; Musoh K; Kawasaki H; Nagai H
Eur J Pharmacol; 1999 Feb; 367(2-3):361-71. PubMed ID: 10079012
[TBL] [Abstract][Full Text] [Related]
7. The effects of serotonin antagonists in a behavioral despair procedure in mice.
Luttinger D; Freedman M; Hamel L; Ward SJ; Perrone M
Eur J Pharmacol; 1984 Dec; 107(1):53-8. PubMed ID: 6526071
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of passive cutaneous anaphylaxis (PCA) by azelastine: dissociation of its antiallergic activities from antihistaminic and antiserotonin properties.
Chand N; Harrison JE; Rooney SM; Sofia RD; Diamantis W
Int J Immunopharmacol; 1985; 7(6):833-8. PubMed ID: 3935586
[TBL] [Abstract][Full Text] [Related]
9. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
10. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
Fukuda T; Saito T; Tajima S; Shimohara K; Ito K
Arzneimittelforschung; 1984; 34(7):805-10. PubMed ID: 6208915
[TBL] [Abstract][Full Text] [Related]
11. Levocabastine: pharmacological profile of a highly effective inhibitor of allergic reactions.
Awouters F; Niemegeers CJ; Jansen T; Megens AA; Janssen PA
Agents Actions; 1992 Jan; 35(1-2):12-8. PubMed ID: 1354927
[TBL] [Abstract][Full Text] [Related]
12. A method for evaluating anti-allergic drugs by simultaneously induced passive cutaneous anaphylaxis and mediator cutaneous reactions.
Koda A; Miura T; Inagaki N; Sakamoto O; Arimura A; Nagai H; Mori H
Int Arch Allergy Appl Immunol; 1990; 92(3):209-16. PubMed ID: 1703513
[TBL] [Abstract][Full Text] [Related]
13. Ketotifen: a histamine release inhibitor.
Martin U; Roemer D
Monogr Allergy; 1977; 12():145-9. PubMed ID: 72350
[No Abstract] [Full Text] [Related]
14. Pharmacological characterization of mouse ear PCA.
Inagaki N; Goto S; Nagai H; Koda A
Int Arch Allergy Appl Immunol; 1985; 78(2):113-7. PubMed ID: 2864316
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of allergic reactions by a new antiallergic drug, LC-6 (trans-2,3b,4,5,7,8b,9,10-octahydronaphthol[1,2-c:5,6-c'] dipyrazole). I. Inhibition of the rat reaginic passive cutaneous anaphylaxis.
Hurtado I; Márquez VE; Vítolo MJ
Int Arch Allergy Appl Immunol; 1978; 57(6):507-13. PubMed ID: 28295
[TBL] [Abstract][Full Text] [Related]
16. Effect of combined histamine H1 and H3 receptor blockade on cutaneous microvascular permeability elicited by compound 48/80.
McLeod RL; Mingo GG; Kreutner W; Hey JA
Life Sci; 2005 Mar; 76(16):1787-94. PubMed ID: 15698856
[TBL] [Abstract][Full Text] [Related]
17. The effects of H1 and H2 receptor antagonism on the response of monkey skin to intradermal histamine, reverse-type anaphylaxis, and passive cutaneous anaphylaxis.
Hutchcroft BJ; Moore EG; Orange RP
J Allergy Clin Immunol; 1979 Jun; 63(6):376-82. PubMed ID: 36420
[TBL] [Abstract][Full Text] [Related]
18. Serotonin type 2 antagonists inhibit lordosis behavior in the female rat: reversal with quipazine.
Mendelson SD; Gorzalka BB
Life Sci; 1986 Jan; 38(1):33-9. PubMed ID: 2934598
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous vascular permeability factors (histamine, 5-hydroxytryptamine, bradykinin) and passive cutaneous anaphylaxis in sheep.
Eyre P
J Pharm Pharmacol; 1970 Feb; 22(2):104-9. PubMed ID: 4392243
[No Abstract] [Full Text] [Related]
20. In vivo pharmacology of astemizole, a new type of H1-antihistaminic compound.
Van Wauwe J; Awouters F; Neimegeers CJ; Janssens F; Van Nueten JM; Janssen PA
Arch Int Pharmacodyn Ther; 1981 May; 251(1):39-51. PubMed ID: 6114717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
